《新股消息》C-LINK SQ(01463.HK) :业务运作不受疫情影响
马来西亚外判文件管理服务商C-LINK SQUARED(01463.HK)董事会主席兼行政总裁Ling Sheng Hwang表示,集团客户主要是来自马来西亚及新加坡的金融机构及保险公司,处理文件的需求较大,日常工作可透过数据传输方式处理,相信新型冠状病毒疫情对业务运作影响不大。
面对大市波动,相信来港上市可提升企业形象及品牌认可度,拓展融资渠道,认为香港是亚洲上市首选地。
截至去年9月底止首三季公司毛利率录40.9%,较2018年同期的36.5%增长4.4个百分点。他解释主要由於期内利润较高的业务例如编程、开发及用户验收测试费用比例增加,相信未来毛利率水平可维持稳定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.